Dantrium
NDC 42023-123, dantrolene sodium, injection, from Par Health USA, LLC.
- Product NDC
- 42023-123
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA018264
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42023-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DANTROLENE SODIUM20 mg/60mL
Pharmacologic classes
Decreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; Skeletal Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42023-123-06 | 42023012306 | 6 VIAL in 1 CARTON (42023-123-06) / 60 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4df35098-8702-46be-ac67-30cfdf1aa570
Use it
Look up 42023-123 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42023-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42023-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.